ascendis pharma glp-1 receptor agonists weight management diabetes treatments Novo pens $285M biobucks deal to use Ascendis' tech to create monthly agonist Novo Nordisk Commits $285M to
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5




























